ArticlePharmaceutical research2017

Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.

Zhengxiong Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.